Researchers have identified an FDA-approved drug that could offer new hope for patients with the rare, fatal genetic disorders Sandhoff and...
Vous n'êtes pas connecté
Researchers have identified antibodies that target Klebsiella pneumoniae, a drug-resistant bacterium, offering potential new treatments for infections.
Researchers have identified an FDA-approved drug that could offer new hope for patients with the rare, fatal genetic disorders Sandhoff and...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
A multidrug-resistant strain of iKlebsiella pneumoniae/i discovered in Brazil highlights a global threat.
In 2022, a strain of iKlebsiella pneumoniae/i isolated from an 86-year-old woman with a urinary infection in Brazil's Northeast region was found to...
A new antibiotic for tuberculosis (TB) targets multidrug-resistant strains, paving the way for advanced treatments and innovative drug development,...
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic bullet’ strategy that combines the...
All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, helping to uncover targets for...
A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age-related macular...
Glaucoma drug methazolamide shows potential in fighting neurodegenerative diseases, offering new hope for treating conditions like Alzheimer's and...
Want to prevent glioblastoma? By applying new techniques like CRISPR/Cas9 screens, scientists have identified new targets for treating glioblastoma,...